Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
213 studies found for:    "Gastrointestinal Stromal Tumors"
Show Display Options
Rank Status Study
21 Unknown  Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: imatinib mesylate;   Procedure: adjuvant therapy
22 Active, not recruiting Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumor (GIST)
Intervention: Drug: imatinib mesylate
23 Completed
Has Results
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: AZD2171
24 Unknown  Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
Conditions: Advanced Renal Cell Carcinoma;   Gastrointestinal Stromal Tumors;   Pancreatic Neuroendocrine Tumors
Intervention: Drug: TH-302
25 Completed Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Everolimus;   Drug: Imatinib
26 Unknown  A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Masitinib;   Drug: Sunitinib
27 Unknown  A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: masitinib (AB1010);   Drug: imatinib
28 Unknown  A Phase 2 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib
Condition: Gastro Intestinal Stromal Tumor
Interventions: Drug: masitinib;   Drug: sunitinib
29 Completed Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors
Condition: Advanced Gastrointestinal Stromal Tumor
Intervention: Drug: AMG 706
30 Recruiting Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib
Condition: Advanced Gastrointestinal Stromal Tumors
Intervention: Drug: PD-0332991 will be administrated orally, formulated as gelatin capsules of 100 mg and 25 mg respectively.
31 Active, not recruiting Symptom Inventory for Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Interventions: Behavioral: Questionnaires;   Behavioral: Interview;   Behavioral: MDASI-GIST Questionnaire
32 Completed Sarcopenia in Patients With Gastrointestinal Stromal Tumours
Condition: Gastrointestinal Stromal Tumours
Intervention: Other: Computed tomography
33 Completed
Has Results
Current Management of Gastrointestinal Stromal Tumors (GIST) in the Region of Coquimbo
Condition: Gastrointestinal Stromal Tumors
Intervention: Other: Observation
34 Completed Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors
Conditions: Carney Complex;   Chondrosarcoma;   Gastrointestinal Stromal Tumor;   Paraganglioma
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Linsitinib;   Other: Pharmacological Study
35 Recruiting A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: sunitinib malate dose escalation;   Drug: sunitinib malate
36 Not yet recruiting A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: BBI503
37 Unknown  Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib mesylate
38 Completed
Has Results
Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation
Conditions: Sarcoma;   Gastrointestinal Stromal Tumors
Intervention: Drug: Imatinib mesylate (Glivec)
39 Completed Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: AUY922
40 Completed
Has Results
Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: dovitinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years